Filing Details

Accession Number:
0001213900-22-037266
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-05 17:00:26
Reporting Period:
2022-06-30
Accepted Time:
2022-07-05 17:00:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1359931 Protara Therapeutics Inc. TARA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192128 M Luke Beshar C/O Protara Therapeutics, Inc.
345 Park Avenue South, 3Rd Floor
New York NY 10010
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-30 10,000 $3.10 198,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct